The steroidal inactivator, exemestane, has a structure very similar to androgen, to androstenedione[...]
The nonsteroidal inhibitors have a mechanism of action that is distinctively different. It blocks cytochrome P450 binding to the substrate on the aromatase inhibitor, but it binds irreversibly. Does that mean anything clinically? I think at this point we don't know for sure, but based on the data presented looking at the aromatase enzyme activity, when you stop a steroidal inhibitor you immediately get a rebound effect of the aromatase enzyme.
In contrast, with exemestane, the steroidal inactivator that binds irreversibly to the enzyme, and when you stop it you have persistent low levels of aromatase.